Melior Pharmaceuticals our pipeline

Melior currently has two active, internal drug programs:

Click any of the programs above to learn more.

Melior Pharmaceuticals is a clinical stage pharmaceutical company developing more effective treatments for metabolic disease, genitourinary and skin disorders. The Company is focused on attractive and untapped markets in disease areas that severely impair a patient's quality of life, such as diabetes, overactive bladder (OAB) and atopic dermatitis. Melior leverages its theraTRACE® repositioning platform and development expertise to identify promising clinical compounds and rapidly advance them towards registration.